Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Addition of Anti-T-Lymphocyte-Globuline As Graft Versus Host Disease Prophylaxis for Matched Unrelated Donors Equalizes Outcomes with Matched Sibling Donors: Results from the AML SCT-BFM 2007 Trial

Blood (2024) 144 (Supplement 1): 3563.

https://doi.org/10.1182/blood-2024-200574

Published: 2024

Journal Articles

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents with GATA2-Related Myelodysplastic Syndrome

Blood (2019) 134 (Supplement_1): 2033.

https://doi.org/10.1182/blood-2019-122403

Published: 2019

Journal Articles

Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies

Blood (2018) 132 (Supplement 1): 3354.

https://doi.org/10.1182/blood-2018-99-110980

Published: 2018

Journal Articles

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 599.

https://doi.org/10.1182/blood.V130.Suppl_1.599.599

Published: 2017

Journal Articles

Response to Front-Line Imatinib Treatment in Children and Adolescents with CML - Data from a Large Pediatric Cohort

Blood (2017) 130 (Supplement 1): 898.

https://doi.org/10.1182/blood.V130.Suppl_1.898.898

Published: 2017

Journal Articles

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000

Blood (2016) 127 (17): 2101–2112.

https://doi.org/10.1182/blood-2015-09-670729

Published: 2016

Includes: Supplemental data

Journal Articles

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

Judith Feucht, Kathrin Opherk, Peter Lang, Simone Kayser, Lena Hartl, Wolfgang Bethge, Susanne Matthes-Martin, Peter Bader, Michael H. Albert, Britta Maecker-Kolhoff, Johann Greil, Hermann Einsele, Paul-Gerhardt Schlegel, Friedhelm R. Schuster, Bernhard Kremens, Claudia Rossig, Bernd Gruhn, Rupert Handgretinger, Tobias Feuchtinger

Blood (2015) 125 (12): 1986–1994.

https://doi.org/10.1182/blood-2014-06-573725

Published: 2015

Includes: Supplemental data

Journal Articles

Clinical Impact Of Post-Transplant Chimerism Monitoring In CD33/34 Bone Marrow Subpopulations and Whole Blood In Pediatric AML: Prospective Comparison Of Highly Sensitive Real Time Sequence Polymorphism PCR Versus Gold-Standard Conventional STR-PCR

Andre Manfred Willasch, MD, Eva Rettinger, MD, Marion Zabel, MD, Hermann Kreyenberg, PhD, Vida Meyer, Arndt Borkhardt, MD, Markus Metzler, MD, Bernhard Kremens, MD, Brigitte Strahm, MD, Wilhelm Woessmann, MD, Christine Mauz-Koerholz, MD, Bernd Gruhn, Stefan Burdach, MD, Michael H Albert, MD, Paul G. Schlegel, MD, Thomas Klingebiel, MD, Peter Bader

Blood (2013) 122 (21): 411.

https://doi.org/10.1182/blood.V122.21.411.411

Published: 2013

Journal Articles

Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004

Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, Michael N. Dworzak, Gudrun Fleischhack, Norbert Graf, Thomas Klingebiel, Bernhard Kremens, Thomas Lehrnbecher, Christine von Neuhoff, Jörg Ritter, Annette Sander, André Schrauder, Arend von Stackelberg, Jan Starý, Dirk Reinhardt

Blood (2013) 122 (1): 37–43.

https://doi.org/10.1182/blood-2013-02-484097

Published: 2013

Includes: Supplemental data

Journal Articles

Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)

Blood (2012) 119 (25): 6016–6024.

https://doi.org/10.1182/blood-2011-12-398958

Published: 2012

Includes: Supplemental data

Journal Articles

Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation

Eva Rettinger, Andre M. Willasch, Hermann Kreyenberg, Arndt Borkhardt, Wolfgang Holter, Bernhard Kremens, Brigitte Strahm, Wilhelm Woessmann, Christine Mauz-Koerholz, Bernd Gruhn, Stefan Burdach, Michael H. Albert, Paul-Gerhardt Schlegel, Thomas Klingebiel, Peter Bader

Blood (2011) 118 (20): 5681–5688.

https://doi.org/10.1182/blood-2011-04-348805

Published: 2011

Includes: Supplemental data

Journal Articles

NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation

Blood (2011) 118 (4): 1181–1184.

https://doi.org/10.1182/blood-2011-05-356451

Published: 2011

Journal Articles

Allogeneic Hematopoetic Stem Cell Transplantation (SCT) In Children with ALL: Outcome of Matched Sibling Donor SCT (MSD-SCT) Is Equivalent to Unrelated Well Matched Donor HSCT (MD-HSCT) A Report From the Prospective International Multicenter Trial ALL-SCT-BFM 2003

Blood (2010) 116 (21): 530.

https://doi.org/10.1182/blood.V116.21.530.530

Published: 2010

Journal Articles

Retransplantation with Stem Cells from Mismatched Related Donors after Graft Rejection in Pediatric Patients.

Peter J. Lang, MD, Johann Greil, MD, Ingo Müller, MD, Peter Bader, MD, Thomas Klingebiel, MD, Frank Heinzelmann, MD, Claus Belka, MD, Bernhard Kremens, MD, Alfred Reiter, MD, Paul G. Schlegel, MD, Rupert Handgretinger, MD

Blood (2006) 108 (11): 2955.

https://doi.org/10.1182/blood.V108.11.2955.2955

Published: 2006

Journal Articles

No Improvement of Overall-Survival in Children with High-Risk Acute Myeloid Leukemia by Stem Cell Transplantation in 1st Complete Remission.

Dirk Reinhardt, MD, Bernhard Kremens, MD, Martin Zimmermann, PhD, Josef Vormoor, MD, PhD, Michael Dworzak, MD, Christine Peters, MD, Ursula Creutzig, MD, Thomas Klingebiel, MD

Blood (2006) 108 (11): 320.

https://doi.org/10.1182/blood.V108.11.320.320

Published: 2006

Journal Articles

Chronic Myeloid Leukemia (CML) in Childhood - Results of the Multicenter-Trial CML-paed.

Meinolf Suttorp, MD, Alexander Claviez, MD, Yvonne Martiniak, Thomas Klingebiel, MD, Dietrich Niethammer, MD, Helmut Gadner, MD, Chris Peters, MD, Hartmut Kabisch, MD, Bernhard Kremens, MD, Felix Zintl, MD, Guenter Henze, MD, Ulrich Goebel, MD

Blood (2004) 104 (11): 617.

https://doi.org/10.1182/blood.V104.11.617.617

Published: 2004

Journal Articles

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors

Mats Remberger, Oolle Ringdén, Igor-Wolfgang Blau, Hellmut Ottinger, Bernhard Kremens, Micheil G. Kiehl, Johan Aschan, Dietrich W. Beelen, Nadezda Basara, Gunilla Kumlien, Axel A. Fauser, Volker Runde

Blood (2001) 98 (6): 1739–1745.

https://doi.org/10.1182/blood.V98.6.1739

Published: 2001

Journal Articles

Improved Treatment Results in Childhood B-Cell Neoplasms With Tailored Intensification of Therapy: A Report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

Alfred Reiter, Martin Schrappe, Markus Tiemann, Wolf-Dieter Ludwig, Elif Yakisan, Martin Zimmermann, Georg Mann, Andreas Chott, Wolfram Ebell, Thomas Klingebiel, Norbert Graf, Bernhard Kremens, Stefan Müller-Weihrich, Hans-Jürgen Plüss, Felix Zintl, Günter Henze, Hansjörg Riehm

Blood (1999) 94 (10): 3294–3306.

https://doi.org/10.1182/blood.V94.10.3294.422k12_3294_3306

Published: 1999

Journal Articles

TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic Leukemia

Karlheinz Seeger, Hans-Peter Adams, Dirk Buchwald, Birgit Beyermann, Bernhard Kremens, Charlotte Niemeyer, Jörg Ritter, Dirk Schwabe, Dörte Harms, Martin Schrappe, Günter Henze

Blood (1998) 91 (5): 1716–1722.

https://doi.org/10.1182/blood.V91.5.1716

Published: 1998

Journal Articles

Transplantation of Filgrastim-Mobilized Peripheral Blood Stem Cells From HLA-Identical Sibling or Alternative Family Donors in Patients With Hematologic Malignancies: A Prospective Comparison on Clinical Outcome, Immune Reconstitution, and Hematopoietic Chimerism

Dietrich W. Beelen, Helmut D. Ottinger, Ahmet Elmaagacli, Birgit Scheulen, Oliver Basu, Bernhard Kremens, Werner Havers, Hans Grosse-Wilde, Ulrich W. Schaefer

Blood (1997) 90 (12): 4725–4735.

https://doi.org/10.1182/blood.V90.12.4725

Published: 1997

NARROW

Addition of Anti-T-Lymphocyte-Globuline As Graft Versus Host Disease Prophylaxis for Matched Unrelated Donors Equalizes Outcomes with Matched Sibling Donors: Results from the AML SCT-BFM 2007 Trial

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents with GATA2-Related Myelodysplastic Syndrome

Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

Response to Front-Line Imatinib Treatment in Children and Adolescents with CML - Data from a Large Pediatric Cohort

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

Clinical Impact Of Post-Transplant Chimerism Monitoring In CD33/34 Bone Marrow Subpopulations and Whole Blood In Pediatric AML: Prospective Comparison Of Highly Sensitive Real Time Sequence Polymorphism PCR Versus Gold-Standard Conventional STR-PCR

Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004

Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)

Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation

NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation

Allogeneic Hematopoetic Stem Cell Transplantation (SCT) In Children with ALL: Outcome of Matched Sibling Donor SCT (MSD-SCT) Is Equivalent to Unrelated Well Matched Donor HSCT (MD-HSCT) A Report From the Prospective International Multicenter Trial ALL-SCT-BFM 2003

Retransplantation with Stem Cells from Mismatched Related Donors after Graft Rejection in Pediatric Patients.

No Improvement of Overall-Survival in Children with High-Risk Acute Myeloid Leukemia by Stem Cell Transplantation in 1st Complete Remission.

Chronic Myeloid Leukemia (CML) in Childhood - Results of the Multicenter-Trial CML-paed.

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors

Improved Treatment Results in Childhood B-Cell Neoplasms With Tailored Intensification of Therapy: A Report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic Leukemia

Transplantation of Filgrastim-Mobilized Peripheral Blood Stem Cells From HLA-Identical Sibling or Alternative Family Donors in Patients With Hematologic Malignancies: A Prospective Comparison on Clinical Outcome, Immune Reconstitution, and Hematopoietic Chimerism

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only